Contact :

Vincent Puard
CEO
contact@mabsilico.com
+33769860902

 Research Areas:

MAbSilico is a software editor having the vision to accelerate the development of therapeutic antibodies using deeptech-driven solutions combining Artificial Intelligence and machine learning. MAbSilico is a deeptech startup – spinoff of CNRS and INRA research team – committed to the fast discovery and development of biomarker and therapeutic antibodies for our biotech costumers.

MAbSilico provides in silico tools for mAb development; epitope mapping, off-target prediction, FTO antibody proposal and target identification based on antibodies sequences.

#insilico, #mAbcharacterization, #epitopemapping, #offtarget

Skills / Know-how:

To help the development of antibodies, four services are available:

• MAbTope : epitope mapping
• MAbTarget : target identification
• MAbCross : off-target identification
• MAbSubstitute : alternative antibody identification

Location :

Centre INRA Val de Loire, Plateforme Zénoé, 37380 Nouzilly, France

 Website :  https://www.mabsilico.com/